Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Bekeken
• 07/09/23
0
0
insluiten
administrator
abonnees
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties